Jordi is making early diagnosis of infectious and non-communicable diseases affordable for disadvantaged communities and poorly funded health systems. By developing his own new technology and delivering it through a global cross subsidization model, he is not only widening the range of easily traceable risk factors for certain chronic diseases, but he is also allowing rich mass-volume data analysis to quickly reach health policy makers.